Freedom Meditech Raises $7 Million Series B to Market New Diabetes Screening Device

Freedom Meditech today announced that it has closed a $7 million Series B financing. Funds will support the U.S. commercial launch of the ClearPath DS-120 Lens Fluorescence Biomicroscope which was cleared by the FDA earlier this year.
DeviceSpace